Le Lézard
Classified in: Health, Science and technology
Subject: Personnel

SpectrumX Adds Financial Controller to Management Team


SpectrumX, a UK-based healthcare and pharmaceutical company, today announces the appointment of Scott Grant as financial controller. Grant joins SpectrumX's finance team ? led by CFO Barry Saint ? at a significant time for the Company, as it grows its commercial offerings and presence across the UK and continental Europe.

Grant will manage financial reporting and control activities for SpectrumX. Grant brings top-grade experience in the life sciences sector, focused on financial reporting, risk management and assurance, gained in the industry with a FTSE-100 listed group and as a practitioner at a Big 4 firm.

Most recently, he worked as lead finance business partner, and previously as financial controller, at Johnson Matthey, where he worked across the life science and technology business. He was also a senior associate at PwC, with a focus on biotech, for both listed and private entities. He holds a first-class honours degree in accounting and finance from the University of Hertfordshire and he is an ACA Charterholder.

Damien Hancox, CEO of SpectrumX, said: "We are delighted to have Scott join our team. With his sector-specific knowledge and audit background, he will be a key addition as we expand our commercial offerings and prepare for the next stage of our growth."

Barry Saint, CFO of SpectrumX, said: "Scott joins our growing business at an exciting time in its development. I am pleased to welcome him to the team. He brings a wealth of expertise, and I am certain that he will make a significant contribution to Company's ongoing success."

- ENDS -

For Investors
SpectrumX is currently conducting a pre-IPO capital raise in advance of a planned listing on the London Stock Exchange. Interested prospective investors can learn more at https://www.spectrumx.com/investor_relations/.

About SpectrumX
SpectrumX is a UK-based healthcare and pharmaceuticals company focused on bringing to market an innovative respiratory infection therapy and the roll-out of the most powerful hand sanitiser in the world to the NHS and other healthcare clients. Both products utilise unique, patent-pending HOCl formulations. HOCl is naturally occurring in human white blood cells and is a key contributor in the immune response to infection. HOCl also has direct killing activity against bacteria, viruses and fungi. It is well-tolerated in humans while also being the most effective known disinfectant when used on surfaces. For more on SpectrumX, visit www.spectrumx.com. For investors, visit https://www.spectrumx.com/investor_relations/.


These press releases may also interest you

at 04:05
Pyramid Analytics (Pyramid), a pioneering business analytics and decision intelligence provider, has appointed Martin McDonald as Vice President DACH. McDonald has held various management positions in global technology companies looking to enter the...

at 04:05
The use of cloud-native solutions in Germany continues to rise, benefiting hyperscale cloud providers such as AWS, as enterprises seek to develop and execute scalable applications, according to a new research report published today by Information...

at 04:00
Prime, a global provider of hyperscale and wholesale data centers, today announced plans to expand its EMEA footprint to Denmark with a 124-megawatt campus. Located at Energivej in Saeby, Prime Denmark features three hyperscale data centers and will...

at 04:00
Trina Storage, the vertically integrated battery energy storage solution provider, today announced the contract closure for another two Battery Energy Storage System (BESS) projects in the UK shortly after the signing of the 50MW/102 MWh Swangate...

at 04:00
BlackBerry Limited today released new research revealing that half (51%) of IT professionals predict that we are less than a year away from a successful cyberattack being credited to ChatGPT, and 71% believe that foreign states may already...

at 04:00
A global leader in automotive cybersecurity and connected mobility technologies, AUTOCRYPT announced its certification for ASPICE Capability Level (CL) 2. One of the very first and few cybersecurity providers to achieve this certification, AUTOCRYPT...



News published on 6 december 2022 at 04:05 and distributed by: